Olivier Bayle

523 total citations
18 papers, 300 citations indexed

About

Olivier Bayle is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Olivier Bayle has authored 18 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 7 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Olivier Bayle's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis C virus research (3 papers). Olivier Bayle is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis C virus research (3 papers). Olivier Bayle collaborates with scholars based in France, Switzerland and United States. Olivier Bayle's co-authors include Patrick Beaurain, O. Monnet, Jean‐Luc Raoul, Hervé Perrier, Marc Bourlière, Xavier Adhoute, Bernard Pol, Guillaume Pénaranda, Paul Castellani and J.-P. Bronowicki and has published in prestigious journals such as Stroke, Journal of Hepatology and Journal of Vascular Surgery.

In The Last Decade

Olivier Bayle

17 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Bayle France 8 188 105 79 71 59 18 300
A Cedrone Italy 13 334 1.8× 306 2.9× 62 0.8× 17 0.2× 120 2.0× 19 528
Giuliano Peta Italy 9 100 0.5× 51 0.5× 85 1.1× 40 0.6× 135 2.3× 25 302
S. Boucebci France 11 95 0.5× 81 0.8× 93 1.2× 8 0.1× 71 1.2× 20 308
Xiaoer Zhang China 11 98 0.5× 63 0.6× 67 0.8× 24 0.3× 108 1.8× 48 284
J. Morris United States 4 51 0.3× 89 0.8× 117 1.5× 16 0.2× 82 1.4× 7 327
Phillip Stanley United States 8 104 0.6× 41 0.4× 126 1.6× 40 0.6× 198 3.4× 9 315
C. Baillet France 9 58 0.3× 52 0.5× 97 1.2× 45 0.6× 45 0.8× 31 231
S C Chan China 6 275 1.5× 147 1.4× 19 0.2× 64 0.9× 192 3.3× 12 392
Kazuharu Igarashi Japan 12 117 0.6× 21 0.2× 100 1.3× 13 0.2× 171 2.9× 31 327
Petros Charalampoudis Greece 10 21 0.1× 41 0.4× 45 0.6× 48 0.7× 76 1.3× 25 220

Countries citing papers authored by Olivier Bayle

Since Specialization
Citations

This map shows the geographic impact of Olivier Bayle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Bayle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Bayle more than expected).

Fields of papers citing papers by Olivier Bayle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Bayle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Bayle. The network helps show where Olivier Bayle may publish in the future.

Co-authorship network of co-authors of Olivier Bayle

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Bayle. A scholar is included among the top collaborators of Olivier Bayle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Bayle. Olivier Bayle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Adhoute, Xavier, Rodolphe Anty, P. Chevallier, et al.. (2021). Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results. World Journal of Clinical Cases. 9(18). 4559–4572. 3 indexed citations
2.
Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2019). Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort. European Journal of Gastroenterology & Hepatology. 31(11). 1414–1423. 3 indexed citations
3.
Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2018). Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case–control study. European Journal of Gastroenterology & Hepatology. 30(4). 368–375. 17 indexed citations
4.
Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2017). Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort. World Journal of Gastroenterology. 23(14). 2545–2545. 20 indexed citations
5.
Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2017). NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization. European Journal of Gastroenterology & Hepatology. 29(6). 706–715. 7 indexed citations
6.
Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2015). Prognosis of advanced hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology. 28(4). 433–440. 27 indexed citations
7.
Adhoute, Xavier, Guillaume Pénaranda, J.F. Blanc, et al.. (2015). P0376 : Stratification of hepatocellular carcinoma. The prognostic score NIACE, an additional aid to the Barcelona Clinic Liver Cancer (BCLC) staging system? Multicenter study. Journal of Hepatology. 62. S453–S453. 1 indexed citations
8.
Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2014). Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process. Journal of Hepatology. 62(4). 855–862. 117 indexed citations
9.
Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2014). P976 RETREATMENT WITH TRANSARTERIAL CHEMOEMBOLIZATION (TACE): THE ABCR SCORE, AN AID TO THE DECISION-MAKING PROCESS. Journal of Hepatology. 60(1). S400–S400. 1 indexed citations
10.
Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2014). P977 UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) TREATED BY TRANSARTERIAL CHEMOEMBOLIZATION (TACE): AFTER TWO SESSIONS, ART OR ABCR SCORES TO GUIDE THE DECISION MAKING PROCESS?. Journal of Hepatology. 60(1). S401–S401. 1 indexed citations
12.
Cheynet, F, et al.. (1999). [RMI of dysfunctional temporomandibular joint (TMJ). Value of gradient-echo T1 sequences in the evaluation of bony structures].. PubMed. 80(11). 1543–54. 5 indexed citations
13.
Héron, Emmanuel, et al.. (1998). Brain Involvement in Scleroderma. Stroke. 29(3). 719–721. 32 indexed citations
14.
Bayle, Olivier, Alain Branchereau, Eugénio Rosset, et al.. (1997). Morphologic assessment of abdominal aortic aneurysms by spiral computed tomographic scanning. Journal of Vascular Surgery. 26(2). 238–246. 49 indexed citations
15.
Bayle, Olivier, et al.. (1994). [Coraco-trochineal conflict or anteromedial conflict of the shoulder. Contribution of arthroscanners].. PubMed. 75(11). 609–17. 2 indexed citations
16.
Lafforgue, Pierre, Christophe Chagnaud, Éric Toussirot, et al.. (1992). [Aspects and role of spinal MRI in the assessment of solitary plasmacytoma and multiple myeloma. Apropos of 11 cases].. PubMed. 59(5). 317–26. 3 indexed citations
17.
Lafforgue, Pierre, et al.. (1991). [MRI in osteoporotic and metastatic vertebral compressions: apropos of 60 cases].. PubMed. 34(3). 157–66. 5 indexed citations
18.
Bayle, Olivier, et al.. (1990). [Idiopathic and secondary Raynaud's phenomenon. A comparative psychosomatic approach].. PubMed. 19(16). 741–5. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026